Tag Archive for: FDA

Increasing Access to Genome Sequencing for Clinical Diagnostics
As genome sequencing continues to decrease in price and increase in demand, the desire for many clinical organizations to leverage genome sequencing as a clinical diagnostic means continues to get traction. In a recent change, the California…